Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease

Journal of the American College of Cardiology

Volumn 40, Issue 1, 2002, Pages 43-48

  Lamblin, Nicolas ^a,b   Bauters, Christophe ^a,b   Hermant, Xavier ^b   Lablanche, Jean Marc ^a   Helbecque, Nicole ^b   Amouyel, Philippe ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; STROMELYSIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY WALL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DIAGNOSTIC IMAGING; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; RISK ASSESSMENT; RISK FACTOR;

ALLELES; CASE-CONTROL STUDIES; CORONARY ANEURYSM; CORONARY ARTERIOSCLEROSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0037014614     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01909-5     Document Type: Article

References (35)

1. Molecular bases of the acute coronary syndromes
2. Coronary artery aneurysms: Study of the etiology, clinical course and effect on left ventricular function and prognosis
3. Aneurysmal coronary artery disease
4. Acquired coronary arterial aneurysms: An autopsy study of 52 patients
5. The natural history of aneurysmal coronary artery disease
6. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm
7. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages
8. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm
9. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta
10. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms
11. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta
12. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908)
13. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms
14. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation
15. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model
16. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: Role of Sp1 in allele-specific transcriptional regulation
17. Preliminary report: Genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis
18. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression
19. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm
20. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease
21. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms
22. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction
23. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis
24. Accuracy and precision of quantitative digital coronary arteriography: Observer-, short-, and medium-term variabilities
25. A simple salting out procedure for extracting DNA from human nucleated cells
26. Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease
27. Matrix metalloproteinases and cardiovascular disease
28. Metalloproteinases in degenerative aortic disease
29. Activation of the 92-KDa gelatinase by stromelysin and 4-aminophenylmercuric acetate: Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP)
30. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall
31. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneuryms
32. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease
33. Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms ("dilated coronopathy")
34. An activated state of blood coagulation and fibrinolysis in patients with abdominai aortic aneurysm
35. Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms